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Mutalysin-II  (mut-II)  from  Lachesis  muta  snake  venom  is an endopeptidase  with  hemorrhagic  activity.  A
mAb  against  mutalysin-II  that  neutralized  the  hemorrhagic  effect  was  produced  previously.  To  identify
the  mAb  epitopes,  sets  of  15-mer  overlapping  peptides  covering  the  mut-II  amino  acid sequence  were
synthesized  using  the SPOT  method  and  tested  but  failed  to  react  with  the mAb.  Using  a phage-display
approach  seventeen  clones  reactive  with  mAb  were  identiﬁed.  Additional  immunoassays  with  the  pep-
tides  and mAb  identiﬁed  the  QCTMDQGRLRCR,  TCATDQGRLRCT,  HCFHDQGRVRCA,  HCTMDQGRLRCR  andeywords:
achesis muta venom
ntivenom
hage-display
ynthetic  peptides
imotope
onoclonal antibody
SCMLDQGRSRCR  sequences  as  possible  epitopes.  Immunization  of rabbits  with  these  peptides  induced
antibodies  that  recognize  mut-II  and  protected  against  the  hemorrhagic  effects  of  Lachesis  venom.
© 2011  Elsevier  Inc.  Open access under the Elsevier OA license.. Introduction
Snake bites are an important public health problem in Brazil.
pproximately 20,000 cases are reported annually, with a mor-
ality rate of 0.5%. Envenomation due to Bothrops sp. and Lachesis
uta accounts for more than 80% of cases [30]. Local or inva-
ive hemorrhage is a major complication of Bothrops and Lachesis
nvenomation; this results from the action of hemorrhagic met-
lloproteinases, also referred to as reprolysins [4]. In addition,
here are secondary factors which are involved in blood coagu-
ation disorders, kinin release and also neurotoxic components
22,23].
Metalloproteinases from viperid snake venoms (SVMPs) disrupt
he vascular basement membrane resulting in typical hemorrhage
4,33]. As observed in other snakes, envenoming by the bush-
aster snake (L. muta muta) leads to the development of both
ocal and systemic bleeding. Two hemorrhagic factors character-
zed as metalloproteinases were named LHF-I and LHF-II (Lachesis
emorrhagic factor I and II), and correspond to mutalysin-I and
utalysin-II (mut-II), respectively [35]. Mutalysin-I is a large pep-
∗ Corresponding author. Tel.: +55 31 3409 2625; fax: +55 31 3441 5963.
E-mail address: olortegi@icb.ufmg.br (C. Chávez-Olórtegui).
196-9781 ©   2011 Elsevier Inc. 
oi:10.1016/j.peptides.2011.06.028
Open access under the Elsevier OA license.tidase (100 kDa) with restricted substrate speciﬁcity and has the
strongest hemorrhagic activity (approximately 30 times higher
than mut-II). Mut-II is a 22.5 kDa single chain protein with broad
substrate speciﬁcity and traces of hemorrhagic effects [35,36]. As
for other SVMPs, mutalysins proteolytically degrade not only ﬁb-
rinogen, but also other extracellular matrix components such as
laminin, ﬁbronectin, type IV collagen or gelatin [34,35]. In addi-
tion, mutalysin-I selectively inhibits collagen-induced aggregation
of human platelets [12].
We  have previously reported that the monoclonal antibody
LmmAbB2D4 [11] and rabbit polyclonal antibodies [39] against
mut-II show cross-reactivity against mutalysin-I and efﬁciently
neutralize the hemorrhagic effects of whole L. muta muta venom
and certain Bothrops venoms (i.e. B. alternatus, B. atrox, B. itape-
tiningae, B. jararaca and B. neuwiedii). Identifying the epitope
of this neutralizing antibody could aid in the preparation of
immunogens for therapeutic serum development or vaccination
approaches. In the present investigation, the peptide phage-display
method [20,40], and the SPOT synthesis technique [17,26,31] were
used together to identify the epitope recognized by LmmAbB2D4.
Rabbits immunized with deﬁned synthetic mimotopes encapsu-
lated in liposomes produced an antibody response capable of
efﬁciently neutralizing the hemorrhagic effect of L. muta crude
venom.
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. Materials and methods
.1.  Animals, L. muta muta snake venom and antibodies
Eight- to nine-week-old New Zealand rabbits were main-
ained at the Centro de Bioterismo, ICB-UFMG (Belo Horizonte,
G, Brazil), and received water and food under controlled
nvironmental conditions. Treatment and handling of all ani-
als used in the experiments followed the requirements of the
thics Committee of Animal Experimentation (CETEA) of UFMG.
he L. muta muta venom was obtained by milking specimens
aptured near Manaus, Amazonas, Brazil and raised at the ser-
entarium of Fundac¸ ão Ezequiel Dias (FUNED), Belo Horizonte,
razil. Mut-II was isolated as previously described by Sanchez
t al. [36]. The neutralizing monoclonal antibody (LmmAbB2D4)
nd the polyclonal antibodies against mut-II were produced as
escribed by Estêvão-Costa et al. [11] and Souza et al. [39], respec-
ively.
.2. Spot synthesis
Overlapping synthetic peptides corresponding to the mut-II
mino acid sequence (GenBank accession number AAQ16123)
ere prepared using the SPOT technique [17]. Two  series
f membrane-bound peptides were synthesized according to
he procedure described by Laune et al. [26] as 15-mer
eptides frameshifted by three residues. After synthesis, non-
peciﬁc binding sites of the membranes were blocked by
ncubation with blocking buffer (Roche, Germany) overnight
t 4 ◦C, and further probed with rabbit serum against mut-
I (diluted 1:400) or with LmmAbB2D4 (1 or 10 g/ml in
locking buffer) for 90 min  at room temperature. Antibody
inding to spots was revealed by incubation (90 min  at
oom temperature) with alkaline phosphatase-conjugated goat
nti-rabbit or goat anti-mouse antibodies and 5-bromo-4-
hloro-3-indolyl phosphate (BCIP) plus 3-(4,5-dimethylthiazol-
-yl)-2,5-diphenyltetrazolium bromide (MTT) as substrate. The
embrane was stripped by sequential treatment with dimethyl-
ormamide, 1% SDS, 0.1% 2-mercaptoethanol in 8 M urea,
thanol/water/acetic acid (50:40:10, v/v/v) and, ﬁnally, methanol
o remove the precipitated dye and molecules bound to the
eptides.
.3. Isolation of phage clones binding to LimAb7
Four different M13  phage libraries expressing 15-mer (X15), 30-
er (X30), 17-mer including a ﬁxed cysteine residue (X8CX8), and
2-mer peptides including two ﬁxed cysteine residues (XCX8CX)
ere employed [40]. Biopannings were performed as described
reviously [40] with some modiﬁcations. Brieﬂy, 96-well microtiter
lates (Becton Dickinson, Oxnard, CA) were incubated overnight at
◦C with 100 l LmmAbB2D4 at 5 g/ml for the ﬁrst two biopan-
ings and 0.5 g/ml for the last one, in 0.1 M NaHCO3, pH 8.6. The
lates were then washed with 0.05% Tween 20 in 50 mM Tris-
uffered saline, pH 7.5 (TBS-T) and blocked with 3% BSA in TBS-T at
7 ◦C for 2 h. For the ﬁrst biopanning, 1.5 × 1011 transducing units
TU) of phages expressing linear 15-mer (X15), 17-mer (X8CX8) and
0-mer (X30) peptides and 2.5 × 1010 TU of phages expressing con-
trained 12-mer (XCX8CX) peptides were incubated in TBS-T with
he immobilized LmmAbB2D4 overnight at 4 ◦C. Unbound phages
ere removed by washing with TBS-T. Bound phages were eluted
ith 0.1 M glycine, 1 mg/ml  bovine serum albumin (pH 2.2) and
eutralized with 2 M Tris–HCl, pH 9.0. Escherichia coli K91 cells
ere infected with the eluted phages and grown overnight at 37 ◦C.
hage particles were precipitated with 20% PEG 8000, 2.5 M NaCl
vernight on ice, resuspended in 0.05 M Tris–HCl, 0.15 M NaCl, pHides 32 (2011) 1640–1646 1641
7.5 and used for the next round of biopanning (2 × 1011 TU). After
three rounds, phage clones were isolated and submitted to screen-
ing ELISA.
2.4. Sandwich ELISA screening assay
Microtiter plate wells (Falcon) were coated with 100 l sheep
anti-M13 polyclonal antibody (10 g/ml) in 0.1 M NaHCO3, pH
8.6, overnight at 4 ◦C. Plates were washed with 0.1% Tween 20-
PBS (PBS-T) and blocked with 2% non-fat dry milk in PBS-T for
1 h at 37 ◦C. The wells were washed, and phages, diluted 1:1 in
PBS-T, were incubated for 90 min  at 37 ◦C. Phages able to bind
LmmAbB2D4 at 10 g/ml were detected by a horseradish per-
oxidise (HRP)-conjugated rabbit anti-mouse antibody (Sigma, St.
Louis, MO,  USA). The clones selected by LmmAbB2D4 were used
in a new ELISA plate conﬁguration to verify their reactivity with
the monoclonal antibody. Plates were sensitized with 5 g/ml
LmmAbB2D4 in coating buffer, washed and blocked as described
previously and incubated with phages at 1 × 1011 to 1 × 106 pfu/ml
diluted in 0.05% Tween 20-PBS for 2 h at 37 ◦C. Binding was detected
using a HRP-conjugated anti-M13 antibody (Sigma) diluted 1:3000
in blocking buffer.
2.5.  DNA sequencing, peptides synthesis on cellulose membranes
and  immunoassay
The single-stranded DNA was  puriﬁed using the QIAprep Spin
M13 protocol (Qiagen). Sequencing reactions were carried out
according to the dideoxy chain termination method using the
ABI Prism Kit using the ABI PRISM 377 (both from PE Applied
Biosystems). The reverse primer 5′-TCGGCAAGCTCTTTTAGG-3′ was
used for sequencing. The sequences obtained were translated and
seventeen dodecapeptides corresponding to the XCX8CX library
were identiﬁed. A cellulose membrane containing the seventeen
peptides was prepared, blocked and probed with LmmAbB2D4
(10 g/ml) as described in Section 2.2.
2.6.  Synthesis, chromatography and mass spectrometry of soluble
peptide
Based  on the results of immunoassay with cellulose-bound
peptides, the peptides recognized by LmmAbB2D4 (QCTMDQ-
GRLRCR, TCATDQGRLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and
SCMLDQGRSRCR) were synthesized manually by Fmoc chemistry
[18]. The peptides were deprotected and released from the resin by
triﬂuoroacetic acid (TFA) treatment in the presence of the appro-
priate scavengers. The peptides were lyophilized and their purity
assessed by HPLC and their mass conﬁrmed by mass spectrome-
try. The synthetic peptides (20 mg  of each) were diluted in 1 ml
of PBS and used for immunogen preparation. The peptides were
puriﬁed by high performance liquid chromatography (HPLC) on a
C18 reverse phase column (ﬂow rate 1.0 mL/min; Vydac). The col-
umn  was equilibrated with 0.1% aqueous TFA, and was eluted by
a linear gradient of 0.1% TFA in acetonitrile. The peaks were then
submitted to MALDI-TOF-TOF analyses. MS  and tandem MS  anal-
ysis were performed using a MALDI-TOF-TOF AutoFlex III (Bruker
Daltonics) instrument in positive/reﬂector mode controlled by the
FlexControl software. Instrument calibration was achieved by using
Peptide Calibration Standard II (Bruker Daltonics) as reference and
-cyano-4-hydroxycinnamic acid was  used as the matrix.2.7.  Liposome preparation and peptide incorporation
The individual peptides were encapsulated in liposomes using
the dehydration–rehydration method [24]. Brieﬂy, multilamellar
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Fig. 1. Anti-mut-II antibody reactivity with membrane bound 15-mer overlapping linear peptides derived from the mut-II amino acid sequence. The 15-mer overlapping
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ainear peptides were probed by rabbit polyclonal anti mut-II at a dilution of 1:4
hosphatase-coupled anti-rabbit or anti mouse antibodies (1:1000).
esicles (MLVs) were prepared in water from an equimolar mix-
ure of cholesterol (CHOL; Sigma) and egg yolk phosphatidylcholine
EPC, 100%; Lipoid) at a 135 g/L ﬁnal lipid concentration, through
he ﬁlm hydration method. Small unilamellar vesicles (SUVs) were
btained by submitting the MLVs suspension to three 5 min-cycles
f ultrasonication using a probe-sonicator (Misonix) under argon
nd in an ice-cold bath. After ﬁltration through a sterile 0.22 m
embrane, the SUVs suspension was mixed with the peptide solu-
ion at a 64:1 lipid-to-peptide mass ratio and the mixture was
mmediately frozen in liquid nitrogen and then dried overnight
freeze-dryer, 4.5 L; Labconco, UK). Dehydration–rehydration vesi-
les (DRVs) were obtained through rehydration of the dried powder
t 25 ◦C as follows: one-tenth of the original SUVs volume of deion- and with LmmAbB2D4 at 10 g/ml (B). Antibodies were detected with alkaline
ized  water was  added, vortexed and incubated for 30 min; 0.1
volume of PBS (0.15 M NaCl, 0.01 M phosphate, pH 7.2) was added,
and the mixture was vortexed prior to the addition of 0.8 volume
of PBS, and then vortexed again and incubated for 30 min. A par-
allel preparation of empty (PBS-loaded) DRVs was also obtained.
The fraction of peptide entrapped in liposomes was determined
indirectly by centrifugation (43,000 × g; 30 min; 4 ◦C) and peptide
titration in the supernatant.2.8.  Immunization protocols
Adult female New Zealand white rabbits (2.0–2.5 kg) were used
for the production of anti-peptide antibodies. After collection of
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Tig. 2. Reactivity of peptides selected by phage display on a SPOT membrane. Lmm
ith  an alkaline-phosphatase coupled anti-mouse antibody. Spot intensities were m
re-immune sera, each animal received an initial subcutaneous
njection of 100 g liposome-trapped synthetic peptide in alu-
inum hydroxide (day 1). Five similar booster injections were
ade 21, 36, 51, 66 and 76 days later. Blood samples were drawn 1
eek after the last injection. As a control, rabbits were also immu-
ized with liposomes not containing synthetic peptides, prepared
s described previously [9].
.9. Indirect ELISA for the determination of anti-peptide
ntibodies
Falcon ﬂexible microtitration plates (Becton Dickinson France
.A.) were coated overnight at 4 ◦C with 5 g/ml mut-II or L. muta
uta whole venom in 0.02 M NaHCO3 buffer, pH 9.6, as described
reviously [3]. Absorbance values were determined at 492 nm with
 Titertek Multiscan spectrophotometer. Tests were done in trip-
icate and the values represent means of experiments. Standard
eviations are represented by error bars. Results were evaluated
y Student’s t-test using Sigma Plot 10.0. In all cases, differences
ere considered signiﬁcant at P < 0.05.
.10. Toxicity assays
Hemorrhagic activity was assayed using the Kondo method [25]
nd adapted by Sanchez et al. [36]. Aliquots of L. muta muta venom
n 100 l physiological saline, or saline alone, were injected into
he dorsal shaved skin of the non-immunized rabbits. Twenty-four
ours later, the rabbits were euthanized and the back skin was
otally removed in order to photograph and measure the hemor-
hagic lesions. One minimum hemorrhagic dose (MHD) was deﬁned
s the dose which causes a hemorrhagic lesion 10 mm in diameter.
he MHD  of L. muta venom used throughout this study was 20 g.4 reactivity with cellulose-bound phage-display identiﬁed peptides was detected
red with the Scion Image software.
For the in vivo neutralization assays of the hemorrhagic activity
of L. muta venom, the immunized and control rabbits were chal-
lenged with L. muta venom 30 days after the last immunization by
intradermal injection of an amount equivalent to 1 MND/kg.
3. Results
3.1. Epitope mapping
In  order to map  the epitope recognized by the neutralizing mon-
oclonal antibody LmmAbB2D4, membrane-bound peptides of 15
amino acids, spanning the entire sequence of mut-II, were probed
with LmmAbB2D4. Only background reactivity was observed at the
highest concentration of the polyclonal antibody (10 g/ml; Fig. 1B
– lower panel). As a control for peptide quality, the 15-mer peptides
(Fig. 1A – upper panel) were reactive when probed with a rabbit
polyclonal antiserum produced against mut-II.
The phage-display system of expression of randomly gen-
erated peptides can identify peptides mimicking discontinuous
epitopes (mimotopes). To identify peptides that would bind to
LmmAbB2D4, four different phage libraries were screened, two of
which expressed linear peptides of either 15 (X15) or 30 amino
acids (X30), whereas the other two displayed peptides includ-
ing either one or two  ﬁxed cysteines and whose sizes were 17
(XCX15) or 12 amino acids (XCX8CX). A signiﬁcant enrichment of
phage binding to the target antibodies was  obtained after three
rounds of biopanning (data not shown). Of approximately one
hundred phage clones randomly picked from the third round of
selection, seventeen clones were selected. The DNA sequence and
the deduced amino acid sequence were determined (Fig. 2A), show-
ing that the peptides were selected from the (XCX8CX) library.
Another cellulose membrane containing the seventeen peptides
Journal Identiﬁcation = PEP Article Identiﬁcation = 68431 Date: August 3, 2011 Time: 8:43 pm
1644 R.A. Machado de Avila et al. / Peptides 32 (2011) 1640–1646
F ity of
d l. Expe
S ative c
w
A
p
8
(
h
3
t
G
t
w
i
w
b
p
t
i
m
o
D
i
R
s
i
a
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iluted  from 1 to 100. The pre-immune sera (control) were used as a negative contro
tandard deviations are represented by error bars. *P < 0.05 compared with the neg
ere prepared, blocked and probed with LmmAbB2D4 (10 g/ml).
s shown in Fig. 2B, the peptides recognized by LmmAbB2D4 were
eptide 4 (QCTMDQGRLRCR), peptide 7 (TCATDQGRLRCT), peptide
 (HCFHDQGRVRCA), peptide 14 (HCTMDQGRLRCR) and peptide 15
SCMLDQGRSRCR). Analysis of these sequences revealed no obvious
omology between the mimotopes and the mut-II sequence.
.2.  Neutralizing ability of anti-peptide antibodies
Based on the results of immunoassay with cellulose-bound pep-
ides, the peptides (QCTMDQGRLRCR, TCATDQGRLRCT, HCFHDQ-
RVRCA and HCTMDQGRLRCR) were synthesized in a soluble form,
rapped in liposomes and used as immunogens in rabbits. One
eek after the sixth injection, sera from rabbits were tested in an
ndirect ELISA for their reactivity toward the peptides, the L. muta
hole venom and the cognate mut-II protein. The sera from rab-
its immunized with peptides show marginal reactivity against the
eptides coated to plates, likely due to low adsorption of peptides
o the microtiter plates (data not shown). However, ELISA reactiv-
ty was observed when the antigens were L. muta crude venom and
ut-II (Fig. 3A and B). The strongest reactivity toward Mut-II was
btained with the serum of rabbits immunized with peptides TCAT-
QGRLRCT and QCTMDQGRLRCR (Fig. 3B). The serum of rabbits
mmunized with the peptides HCFHDQGRVRCA and HCTMDQGRL-
CR reacted poorly with the Mut-II protein, even lower that the
erum of mock-liposomes immunized rabbits.The neutralizing properties of the anti-peptide antibodies raised
n rabbits were assessed in vivo by testing the hemorrhagic inducing
ctivity of L. muta venom in animals immunized with the four tar-
et peptides. The rabbits immunized with the peptide-mimotopes peptide-immunized rabbit sera with L. muta whole venom (A) and mut-II (B) were
riments were performed in triplicate; the values are the means of the experiments.
ontrol.
TCATDQGRLRCT and QCTMDQGRLRCR were completely protected
(Fig. 4A and B). The rabbits immunized with the HCFHDQGRVRCA
and HCTMDQGRLRCR peptides were partially protected (about 62%
and 37% protection, respectively). The animal from the group that
received the empty liposome (without peptides) as negative control
liposome was  not protected.
4.  Discussion
Snake venoms are a cocktail of biologically active molecules,
including toxins with enzymatic and non-enzymatic activities that
have evolved to assist in the capture and digestion of prey, as
well as defense against predators. Human systemic envenoma-
tion is associated with a number of adverse effects, the nature and
severity of which depends on the species of snake, the quantity of
venom injected and the time period between envenomation and
the administration of appropriate medical treatment. These effects
may include paralysis, myolysis, blood coagulation disturbances
and renal damage [7,41]. Bushmaster snake envenomation is char-
acterized by serious hemorrhage, blood coagulation disorders, and
renal failure; hemorrhage is the major complication resulting from
envenomation by the pit vipers Bothrops and Lachesis snakebites
[22]. Hemorrhagic metalloproteinases are important contributors
to local and systemic hemorrhage in human snakebite victims. Two
of these metalloproteinases, originally called Lachesis hemorrhagic
factors I and II (LHF-I and LHF-II; corresponding to mutalysin-I and
mut-II), were previously puriﬁed and characterized [37]. Mut-II is a
P-I class SVMP single chain protein of 22.5 kDa with broad substrate
speciﬁcity and a minor hemorrhagic effect [38].
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Fig. 4. Neutralization of the L. muta muta venom hemorrhagic effect measured in vivo in peptide-immunized rabbits. Hemorrhage was  assessed on the visceral side of the
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f  the control hemorrhage. Control animals were immunized with empty liposome
Our previous results showed that the neutralizing monoclonal
ntibody LmmAbB2D4, produced against L. muta muta venom, rec-
gnizes mut-II and neutralizes the hemorrhagic effect of L. muta
nd several Bothrops crude venoms [11,39]. However, the ability
f LmmAbB2D4 to neutralize the whole venom is likely due to
he recognition of several venom proteins that share the same
pitopic region [11]. Since several continuous antigenic regions
f mut-II were previously identiﬁed [15], herein we  mapped the
ut-II epitope recognized by LmmAbB2D4 to determine if it cor-
esponds to known antigenic regions. We  ﬁrst used the peptide
canning method to map  continuous and discontinuous epitopes
2,6,10,14,27,28]. Sets of 15-mer overlapping peptides covering the
ut-II amino acid sequence were chemically synthesized by the
POT method of multiple peptide synthesis [26,31]. Such linear
eptides were, however, not recognized, indicating that the epitope
s likely discontinuous. Consequently, the phage-display technique
as used. Although libraries of ﬁlamentous phages have often led to
he identiﬁcation of peptides with high homology to the wild type
equence of the epitope [8,13,32], we have identiﬁed, like others
1,16,19], peptides (mimotopes) mimicking discontinuous compo-
ents of the epitope. All seventeen identiﬁed peptides contain two
ysteine residues. Thus, the peptides must be constrained to be rec-
gnized, suggesting that the antibody is sensitive to conformation.
e note, however, that the peptides QCTMDQGRLRCR, TCATDQ-
RLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and SCMLDQGRSRCRon percentage of hemorrhage lesion (B) measured was calculated as the percentage
were  able to bind LmmAbB2D4 when prepared as synthetic replicas
of the phage-born sequences. This can be due to the different con-
formations the peptide adopts in the cellulose membranes when it
is prepared as a synthetic peptide, compared to the conformations
it adopts when displayed on phage surface [29]. The amino acid
sequences of the phage-selected peptides had no homology with
the sequence of Mut-II protein, and thus are considered mimotopes.
Phage-display peptide libraries have identiﬁed mimotopes of
toxins from scorpion and snake venoms. Such peptides stimulate
the production of neutralizing antibodies [5,19,21]. Our results
show, for the ﬁrst time, the usefulness of peptide mimotopes for
the neutralization of hemorrhagic activity induced in animals by
bushmaster snake venom. Given that synthetic epitopes derived
from mut-II sequences permit the development of efﬁcient mut-II
antivenom [15] and that two mimotopes are capable of inducing
a signiﬁcant neutralizing humoral response against L. muta muta
snake venom, these synthetic immunogens will allow for thera-
peutic serum development or for vaccination approaches.
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